Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/147080
Title: Progress in Understanding Cystic Fibrosis
Authors: Dinesh Sriramulu
Issue Date: 2017
Publisher: IntechOpen
link: https://www.intechopen.com/books/progress-in-understanding-cystic-fibrosis
Keywords: Genetics;Staphylococcus aureus;bacteriophage;phage therapy;vB_SauM-fRuSau02;Twortlikevirus;antibiotic;antimicrobial resistance;magistral preparation;compounding pharmacy;phage therapy;regulatory framework;personalized medicine;bacteriophage;phage;horizontal gene transfer;co-evolution;phage therapy;industrial phage application;antimicrobial resistance (AMR);Germany;pH stability;phage-host interactions;genomics;antibiotic-resistance;phage preparation;lysins;biofilms;typhoid fever;Salmonella Typhi;extended-spectrum beta lactamases (ESBL);Democratic Republic of the Congo;bacteriophages;MALDI-MS;Staphylococcus;bacteriophages;phage therapy;Kayvirus;Viral proteins;bacteriophage;therapy;phage therapy;bacterial disease;infection;target selection;Bacteriophage;phage therapy;resistance;adaptation;prophage;production;regulation;phage therapy;viral genomes;best practices;IND;high-throughput sequencing;bacteriophages;phages;food safety;foodborne illness;phage therapy;history of science;science communication;bacteriophage;phage therapy;sustainable agriculture;zoonosis;antibiotic resistance;phage therapy;experimental therapy;phage cocktails;anti-phage antibodies;prophage;immunomodulation;phage therapy;evolution;bacterial resistance;virulence;Listeria ivanovii;bacteriophages;alginate;production;disinfection;phagodisinfection;virus–host interactions;bacteriophage efficacy;gastrointestinal tract;phage therapy;bacteriophage;phage therapy;antimicrobial resistance;antibiotic;global health;developing countries;infectious disease;bacteriophage;phage;phage therapy;phage-resistance;phage therapy;bacterial infection;capsule depolymerase;antibiotic;animal model;bacterial resistance;bacteriophage;immunology;innate immunity;adaptive immunity;human host;phage-human host interaction;bacterial infection;antibiotic resistance;bacteriophage;antibiotic therapy;phage therapy;cases report;abortive infection;prophage;adsorption;Enterococcus;rhamnopolysaccharide;bacteriophage;phage therapy;Staphylococcus aureus;biofilm;antimicrobial;frequency of resistance;phage sensitivity;resistance management;nontraditional antibacterial;bacteriophages;phage therapy;antibiotic resistance;Pseudomonas aeruginosa;Escherichia coli;Staphylococcus aureus;Brussels;Belgium;phage biocontrol;patent landscape;crop production;bacteriophage;phage therapy;multidrug-resistant bacteria;antimicrobial resistance;bacteriophage therapy;compassionate use;antibiotic resistance;phage therapy;PTMP;ATMP;regulatory framework;pharmaceutical paradigm shift;clinical trial;magistral formula;personalized medicine;phage therapy;E. faecalis;OrthoMCL;antimicrobial resistance;capsule;Galleria mellonella;Klebsiella pneumoniae;phage therapy;n/a;antimicrobial resistance;bacteriophage;personalised medicines;phage therapy;pharmaceutical legislation;regulatory framework
ISBN: 9789535132912 9789535132929
Theme:教科書-自然科學類

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.